Login / Signup
Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy.
Amrita Goyal
Seth Lofgreen
Evan Mariash
Andrea Bershow
Kevin J Gaddis
Published in:
Dermatologic therapy (2020)
Keyphrases
</>
atopic dermatitis
cancer therapy
combination therapy
replacement therapy